Articles From: Immersion and LeTV to Launch Tactile Video Experience to ImmunoGen, Inc. Announces Encouraging IMGN529 Clinical Data Presented at 56th ASH Annual Meeting and Exposition


2015/2/17
Immersion Corporation (NASDAQ:IMMR), the leading developer and licensor of touch feedback technology, today announced the company will work with a leading Chinese entertainment company, LeTV (300104.SZ), as the first company in China to debut Immersion-powered tactile video experience on a mobile device.
Sign-up for Immersion and LeTV to Launch Tactile Video Experience investment picks
2015/2/3
Immersion Corporation (NASDAQ:IMMR), the leading developer and licensor of touch feedback technology, today announced that it has entered into a new license agreement with MEIZU Technology Co.
Sign-up for Immersion Announces New License Agreement with MEIZU for TouchSense Tactile Feedback Technology investment picks
2015/2/26
Immersion Corporation (NASDAQ: IMMR), the leading developer and licensor of touch feedback technology, today reported financial results for the fourth quarter and year ended December 31, 2014.
Sign-up for Immersion Corporation Reports Fourth Quarter and Fiscal 2014 Results investment picks
2015/2/26
Immersion Corporation (Nasdaq:IMMR), the leading developer and licensor of touch feedback technology, today announced that John Veschi has joined its Board of Directors, effective February 25, 2015.
Sign-up for Immersion Names John Veschi to Its Board of Directors investment picks
2015/2/26
Immersion Corporation (NASDAQ:IMMR), the leading developer and licensor of touch feedback technology, today announced the Instinctive Alerts Framework, a groundbreaking approach to tactile notifications designed to take advantage of the unique communications capabilities of wearable devices.
Sign-up for Immersion Redefines Wearables Communication With Instinctive Alerts Framework investment picks
2015/2/24
Immersion Corporation (NASDAQ:IMMR), the leading developer and licensor of touch feedback technology, announced today that members of the executive management team will present to the investment community at The JMP Securities Technology Conference on Monday, March 2, 2015 at 12:30 pm PT.
Sign-up for Immersion to Present at the JMP Securities Technology Conference investment picks
2015/1/7
Immersion Corporation (NASDAQ:IMMR), the leading developer and licensor of touch feedback technology, announced today that members of the executive management team will present to the investment community at the following investor conferences: Sidoti & Company LLC Emerging Growth Institutional Investor Forum Date: Monday, January 12, 2015 Time: 2:40 pm ET Location: The Grand Hyatt Hotel, New York, NY Needham Growth Conference Date: Tuesday, January 13, 2015 Time: 12:45 pm ET Location: New York Palace Hotel, New York, NY Certain audio webcasts will be accessible on the "Events & Presentations" page of Immersion’s Investor Relations website at http://ir.immersion.com/events.cfm .
Sign-up for Immersion to Present at Upcoming Investor Conferences investment picks
2015/2/3
Immersion Corporation (NASDAQ:IMMR), the leading developer and licensor of touch feedback technology, announced today that it will report financial results for the fourth quarter and fiscal year 2014 on Thursday, February 26, 2015 after the close of market.
Sign-up for Immersion to Report Fourth Quarter and Fiscal Year 2014 Results and Host Quarterly Conference Call on February 26th investment picks
2015/2/11
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1174722&ProfileId=051205&sourceType=1 PORTLAND, ME --
Sign-up for ImmuCell Announces Financial Results for 2014 investment picks
2015/2/25
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1177430&ProfileId=051205&sourceType=1 PORTLAND, ME --
Sign-up for ImmuCell Reports Results From Rotavirus Pivotal Effectiveness Study investment picks
2015/2/4
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1173007&ProfileId=051205&sourceType=1 PORTLAND, ME --
Sign-up for ImmuCell to Announce 2014 Full Year and Fourth Quarter Financial Results investment picks
2015/2/11
SEATTLE and SOUTH SAN FRANCISCO, Feb.
Sign-up for Immune Design Announces First Patients Dosed in Phase 1 Clinical Trial of G100 Investigational Immuno-Oncology Agent investment picks
2015/2/5
SEATTLE and SOUTH SAN FRANCISCO, Calif., Feb.
Sign-up for Immune Design to Present at the 2015 Leerink Global Healthcare Conference investment picks
2015/1/7
SEATTLE and SOUTH SAN FRANCISCO, Calif., Jan.
Sign-up for Immune Design to Present at the 33rd Annual J.P. Morgan Healthcare Conference investment picks
2015/2/24
SEATTLE and SOUTH SAN FRANCISCO, Feb.
Sign-up for Immune Design to Present at Upcoming Investment Conferences investment picks
2015/1/21
NEW YORK and HERZLIYA PITUACH, Israel , Jan.
Sign-up for Immune Pharmaceuticals Appoints Gad Berdugo as Chief Financial Officer and Dr. Cameron Durrant as Lead Independent Director investment picks
2015/2/9
NEW YORK , Feb.
Sign-up for Immune Pharmaceuticals Appoints Paul Nadler, MD, EVP, R&D and Chief Medical Officer investment picks
2014/12/15
NEW YORK and HERZLIYA PITUACH, Israel , Dec.
Sign-up for Immune Pharmaceuticals Elects Daniel Kazado as New Chairman of the Board. investment picks
2015/2/5
NEW YORK , Feb.
Sign-up for Immune Pharmaceuticals To Present At The BIO CEO & Investor Conference investment picks
2015/3/3
NEW YORK , March 3, 2015 /PRNewswire/ -- Immune Pharmaceuticals Inc. ("Immune", the "Company") (NASDAQ: IMNP) announced today that Dr.
Sign-up for Immune Pharmaceuticals To Present At The Roth Conference investment picks
2014/12/17
LOS ANGELES , Dec.
Sign-up for ImmunoCellular Therapeutics Announces Issuance of Key Patent For ICT-107 Cancer Vaccine investment picks
2015/3/3
LOS ANGELES , March 3, 2015 /PRNewswire/ -- ImmunoCellular Therapeutics, Ltd.
Sign-up for ImmunoCellular Therapeutics to Present at ROTH Conference on March 10th investment picks
2015/1/28
LOS ANGELES , Jan.
Sign-up for ImmunoCellular Therapeutics to Present at the BIO CEO & Investor Conference on February 9, 2015 investment picks
2015/3/2
LOS ANGELES , March 2, 2015 /PRNewswire/ -- ImmunoCellular Therapeutics, Ltd.
Sign-up for ImmunoCellular Therapeutics to Report 2014 Financial Results on March 9, 2015; a Business Update Conference Call and Webcast is Scheduled for March 12, 2015 investment picks
2015/2/12
LOS ANGELES , Feb.
Sign-up for ImmunoCellular Therapeutics, Ltd. Announces Pricing of a Public Offering of Common Stock and Warrants investment picks
2014/12/19
ImmunoGen, Inc. (NASDAQ: IMGN), a biotechnology company that develops novel anticancer therapeutics using its antibody-drug conjugate (ADC) technology, today reported that Roche has announced top-line results of its Phase III MARIANNE study.
Sign-up for ImmunoGen Reports Roche Has Provided an Update on the MARIANNE Trial investment picks
2015/1/11
ImmunoGen, Inc .
Sign-up for ImmunoGen, Inc. Announces 2015 Outlook for Product Pipeline investment picks
2015/1/21
ImmunoGen, Inc .
Sign-up for ImmunoGen, Inc. Announces Conference Call to Discuss its Second Quarter Fiscal Year 2015 Financial Results investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Immersion and LeTV to Launch Tactile Video Experience to ImmunoGen, Inc. Announces Encouraging IMGN529 Clinical Data Presented at 56th ASH Annual Meeting and Exposition
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent